Stockscreener 앱 받기
3.27
5.14%
0.16
시장 영업 전:
3.50
0.23
+7.03%
Dare Bioscience Inc 주식(DARE)의 최신 뉴스
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Dare Bioscience | DEFA14A: Others - Moomoo
Form ARS Dare Bioscience, Inc. For: Dec 31 - StreetInsider
Daré Bioscience (DARE) seeks approval for Lincoln Park share facility and 1.5M-plan increase - Stock Titan
Daré outlines expanded dual path strategy targeting $4.5B hormone therapy market while accelerating commercialization in Q4 2025 - MSN
Dare Bioscience FY 2025 earnings preview - MSN
Daré Bioscience Posts Updated Corporate Investor Presentation Online - The Globe and Mail
Daré Bioscience (DARE) posts updated corporate investor presentation - Stock Titan
Dare Bioscience completes closing of Regulation A offering of preferred stock and warrants - Investing.com UK
Daré Bioscience Completes Regulation A Preferred Stock Offering - TipRanks
Daré Bioscience (NASDAQ: DARE) closes 20,000-unit Regulation A sale - Stock Titan
DARE Surges As Daré Bioscience Unveils Women’s Health Catalysts - StocksToTrade
DARE Surges As Daré Bioscience Launches Women’s Sildenafil Cream - timothysykes.com
DARE Bioscience Jumps As DARE to PLAY Launch and Pipeline Catalysts Draw Focus - StocksToTrade
DARE Bioscience Jumps As DARE to PLAY Launch Highlights Catalyst Path - timothysykes.com
Daré Bioscience Rebalances Classified Board Structure and Terms - TipRanks
Daré Bioscience (DARE) reclassifies director to rebalance staggered board - Stock Titan
Daré Bioscience (NASDAQ: DARE) asks shareholders to approve 1.5M plan shares, vote June 11 - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
DARE Technical Analysis | Trend, Signals & Chart Patterns | DARE BIOSCIENCE INC (NASDAQ:DARE) - ChartMill
Dare Bioscience completes closing of Regulation A equity offering By Investing.com - Investing.com Australia
DARÉ BIOSCIENCE, INC. Files Form 8-K Report with SEC for Unregistered Sales of Equity Securities – April 2026 - Minichart
Dare Bioscience completes closing of Regulation A equity offering - Investing.com
Daré Bioscience (NASDAQ: DARE) closes Regulation A sale of 3,470 units - Stock Titan
Maxim Group Maintains Dare Bioscience(DARE.US) With Buy Rating, Maintains Target Price $8 - Moomoo
LEXX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Head-To-Head Review: Dare Bioscience (NASDAQ:DARE) & Appili Therapeutics (OTCMKTS:APLIF) - Defense World
Maxim Group Upgrades Daré Bioscience (DARE) - MSN
Dare Bioscience | QUALIF: Others - Moomoo
Dare Bioscience, Inc. (DARE) reports Q4 loss, lags revenue estimates - MSN
Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update - The Manila Times
Dare Bioscience Q4 2025 Earnings Call Transcript - MarketBeat
Transcript : Daré Bioscience, Inc., 2025 Earnings Call, Mar 26, 2026 - marketscreener.com
Dare Bioscience, Inc. (DARE) Announces Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
Dare Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Earnings call transcript: Daré Bioscience Q4 2025 highlights capital efficiency By Investing.com - Investing.com India
Earnings call transcript: Daré Bioscience Q4 2025 highlights capital efficiency - Investing.com
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Daré Bioscience, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:DARE) 2026-03-26 - Seeking Alpha
Q4 2025 Dare Bioscience Inc Earnings Call Transcript - GuruFocus
Daré Bioscience (NASDAQ: DARE) expands dual-path women’s health model - Stock Titan
Daré Bioscience (NASDAQ: DARE) details 2025 loss, funding boost and upcoming product launches - stocktitan.net
DARE: DARE to PLAY launches nationwide, with multi-product revenue growth expected in 2026-2027 - TradingView
Dare Bioscience Inc (DARE) Q4 2025 Earnings Report Preview: What To Expect - GuruFocus
Dare Bioscience Inc expected to post a loss of 43 cents a shareEarnings Preview - TradingView
A Viagra ingredient is now in a topical cream developed for women - Stock Titan
On National Viagra Day, Women Finally Claim Their Turn: - Bitget
Dare Bioscience (DARE) Expected to Announce Earnings on Monday - Defense World
Daré Bioscience to Host Full Year 2025 Financial Results and Company Update Conference Call and Webcast on March 26, 2026 - The Manila Times
0.14%
0.48%
자본화:
|
볼륨(24시간):